complete the reaction. At the present time we do not have
evidence to strongly support or eliminate either mechanism.
The initial experiments were carried out on 2-acylpyrroles.
Thus, portionwise addition of a stoichiometric amount of
lauroyl peroxide (over 12 h) to a boiling solution of pyrrole 6 (1
equiv.) and xanthate 7 (1.2 equiv.) in dichloroethane (2 mL
mmol21) led to alkylation at C-5 and furnished 8 in good yield.†
Under identical reaction conditions, acetonyl radical derived
from xanthate 9 efficiently added to pyrroles 6 and 11 to furnish
10 and 12 respectively (Table 1, entries 2 and 3). The
regiochemistry of these reactions is in accordance with SOMO–
HOMO predictions.3d Similarly the 5-benzoylpyrrol-2-yl ace-
tate derivative 14 could be prepared in very high yield (Table 1,
entry 4). This molecule contains the basic structural features of
the important non-steroidal antiinflammatory agents tolmetin
and amtolmetin guacil,6 both of which should be accessible
using the methodology described herein. Thiophene and furan
systems can also be alkylated. This is illustrated by the synthesis
of 16 and 19, which were obtained by radical addition of the
appropriate xanthate to 15 and 18, respectively (Table 1, entries
5 and 6). In the case of the thiophene system, a significant
quantity of the 2,3-disubstituted derivative 17 was also
generated. The reaction of indole 20 and xanthate 9 gave the
2-substituted compound 21 with high regioselectivity, a pre-
viously observed phenomenon,3a fully consistent with the
significant HOMO coefficient at C-2 of indole3e (Table 1, entry
7). It is worth noting that electrophilic substitution reactions of
indole, including alkylations, occur at C-3.
2-Arylpropionic acids constitute a large class of nonsteroidal
antiinflammatory drugs, which are used worldwide. A concise
approach to 2-heteroarylpropionic acids consists in simply
using the secondary xanthate 25 (Table 2). The tiaprofenic acid
ester 26 was thus prepared in good yield from commercially
available 2-benzoylthiophene 24. Likewise the reaction of the
xanthate 25 and pyrrole 13 afforded 2-(5-benzoylpyrrol-
2-yl)propionic acid ethyl ester 27 in high yield along with small
quantities of recovered starting material.
Even though the process has not yet been fully optimised it is
clear that the xanthate-mediated intermolecular oxidative
radical alkylation of various heteroaromatic systems can be
effected in preparatively useful yields. The present radical
based, tin-free approach could be used, in principle, to provide
rapid access to various medicinally important compounds, such
as nonsteroidal antiinflammatory drugs.
Notes and references
† Typical experimental procedure: A solution of the xanthate (1.2 mmol)
and the heteroaromatic compound (1 mmol) in degassed 1,2-dichloroethane
(2 mL mmol21) was heated at reflux, and a solution of dilauroyl peroxide
(1–1.2 mmol) in 1,2-dichloroethane (0.5 mL mmol21) was added dropwise
over a 12 h period. The reaction was monitored by TLC. The solvent was
removed under reduced pressure and the crude residue was purified by
chromatography on a silica gel column (ethyl acetate/hexane) to furnish the
desired product. Selected spectroscopic data: 8 as a white solid m.p. 57–59
°C; IR (KBr cm21): 2929, 1727, 1659; 1H NMR (300 MHz, CDCl3) d/ppm:
9.48 (s, 1H), 6.86 (d, J = 3.9 Hz, 1H), 6.17 (d, J = 3.9 Hz, 1H), 4.18 (q,
J = 7.2 Hz, 2H), 3.90 (s, 3H), 3.67 (s, 2H), 1.27 (t, J = 7.2 Hz, 3H); 13
C
NMR (75 MHz, CDCl3) d/ppm: 179.3, 168.9, 135.9, 132.4, 124.1, 110.7,
61.4, 32.5, 32.4, 14.1. HRMS FAB (M + 1, m/z) calcd for C10H14O3N1:
196.0974, found: 196.097. 14 m.p. 156–158 °C (Lit.7 158–159 °C); HRMS
FAB (M + 1, m/z) calcd for C15H16O3N1: 258.1130, found: 258.1139. 21 as
a white solid m.p. 25–26 °C. (Lit.8 24.5–25 °C), HRMS FAB (M + 1, m/z)
calcd for C12H14O2N1: 204.1025, found: 204.1017.
1 (a) A. Studer, in Radicals in Organic Synthesis, ed. P. Renaud and M.
Sibi, Wiley VCH, Weinheim, 2001, vol. 2, pp. 62–76; (b) J. A. Murphy
and M. S. Sherburn, Tetrahedron, 1991, 47, 4077; (c) F. Suzuki and K.
Kuroda, J. Heterocycl. Chem., 1993, 30, 811; (d) Y. Antonio, E. de la
Cruz, E. Galeazzi, A. Guzman, B. L. Bray, R. Greenhouse, L. J. Kurz, D.
A. Lustig, M. L. Maddox and J. M. Muchowski, Can. J. Chem., 1994, 72,
15; (e) C. T. Tim, K. Jones and J. Wilkinson, Tetrahedron Lett., 1995, 36,
6743; (f) S. Osaki, H. Mitoh and H. Ohmori, Chem. Pharm. Bull., 1996,
44, 2020; (g) P. A. Dobbs, K. Jones and K. T. Veal, Tetrahedron, 1997,
53, 8287; (h) F. Aldabbagh, W. R. Bowman and E. Mann, Tetrahedron
Lett., 1997, 38, 7937; (i) F. E. Ziegler and M. Belema, J. Org. Chem.,
1997, 62, 1083; (j) C. J. Moody and C. L. Norton, J. Chem. Soc., Perkin
Trans. 1, 1997, 2639; (k) D. Harrowen and M. I. T. Nunn, Tetrahedron
Lett., 1998, 39, 5875; (l) F. Aldabbagh, W. R. Bowman, E. Mann and A.
M. Z. Slawin, Tetrahedron, 1999, 55, 8111; (m) J. Marco-Contelles and
M. Rodríquez-Fernández, Tetrahedron Lett., 2000, 41, 381; (n) W. R.
Bowman and E. Mann, J. Chem. Soc., Perkin Trans. 1, 2000, 2991.
2 (a) F. Gagosz and S. Z. Zard, Org. Lett., 2002, 4, 4345; (b) T. Kaoudi, B.
Quiclet-Sire, S. Seguin and S. Z. Zard, Angew. Chem., Int. Ed., 2000, 39,
732; (c) J. Axon, L. Boiteau, J. Boivin, J. E. Forbes and S. Z. Zard,
Tetrahedron Lett., 1994, 35, 1719; (d) A. Liard, B. Quiclet-Sire, R. N.
Saicic and S. Z. Zard, Tetrahedron Lett., 1997, 38, 1759; (e) N. Cholleton
and S. Z. Zard, Tetrahedron Lett., 1998, 39, 7295; (f) T.-M. Ly, B.
Quiclet-Sire, B. Sortais and S. Z. Zard, Tetrahedron Lett., 1999, 40,
2533.
3 (a) E. Baciocchi, E. Muraglia and G. Sleiter, J. Org. Chem., 1992, 57,
6817; (b) E. Baciocchi and E. Muraglia, Tetrahedron Lett., 1993, 34,
3799; (c) I.-S. Cho and J. M. Muchowski, Synthesis, 1991, 567; (d) D. R.
Artis, I.-S. Cho and J. M. Muchowski, Can. J. Chem., 1992, 70, 1838; (e)
D. R. Artis, I.-S. Cho, S. Jaime-Figueroa and J. M. Muchowski, J. Org.
Chem., 1994, 59, 2456.
4 Radical alkylation of heteroaromatic compounds with organic peroxides:
(a) M. Yoshida, T. Yoshida, M. Kobayashi and N. Kamigata, J. Chem.
Soc., Perkin Trans. 1, 1989, 909; (b) M. Aiura and Y. Kanaska, Chem.
Pharm. Bull., 1975, 23, 2835; (c) R. Bonnet, P. Cornell and A. F.
McDonagh, J. Chem. Soc., Perkin Trans. 1, 1976, 794.
We thank DGAPA (205901) for generous financial support
and Dr. Joseph M. Muchowski for many friendly discussions.
Also we thank R. Patiño, J. Pérez, L. Velasco, H. Rios, N.
Zavala, E. Huerta and A. Peña for technical support.
Table 2 Synthesis of 2-heteroarylpropionic acid derivativesa
Entry
Substrate
Xanthate
Product
5 S. Z. Zard, in Radicals in Organic Synthesis, ed. P. Renaud and M. Sibi,
Wiley VCH, Weinhem, 2001, pp. 90–108; S. Z. Zard, Angew. Chem., Int.
Ed. Engl., 1997, 36, 672.
6 (a) T. Y. Shen, Angew. Chem., Int. Ed. Engl., 1972, 6, 460; (b) D.
Lednicer and L. A. Metscher, The Organic Chemistry of Drug Synthesis,
Wiley, New York, 1977, vol. 1, pp. 85–92, 267–277; D. Lednicer and L.
A. Metscher, The Organic Chemistry of Drug Synthesis, Wiley, New
York, 1980, vol. 2, pp. 63–83; (c) K. Hino, H. Nakamura, Y. Nagai, H.
Uno and H. Nishimura, J. Med. Chem., 1983, 26, 222; (d) C. Giordano,
G. Castaldi and F. Uggeri, Angew. Chem., Int. Ed. Engl., 1984, 23, 413;
(e) J. P. Rieu, A. Boucherle, H. Course and G. Mounzin, Tetrahedron,
1986, 42, 4095; (f) The Merck Index, 11th edn., Merck, Rahway, NJ,
1989.
1
75%
2
81% (90%)
7 J. F. P. Andrews, M. P. Jackson and C. J. Moody, Tetrahedron., 1993, 49,
7353.
8 J. Gudjons, R. Oehl and P. Rosenmund, Chem. Ber., 1976, 109, 3282.
a Yields in parentheses are based on recovered starting material.
CHEM. COMMUN., 2003, 2316–2317
2317